pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Kite Pharma Inc · news · pharmadog
← back to Kite Pharma Inc
News mentioning Kite Pharma Inc
12
stories
1d
AstraZeneca, Calidi, Tempest make significant workforce cuts
biospace
6d
Cellectis will shed 70% of workforce as part of in vivo pivot
fiercebiotech
20d
Gilead reveals partial clinical hold on 2 CAR-T cell therapy trials
fiercebiotech
22d
Parkinson’s-focused Aspen and bispecific biotech Bambusa both shoot for $134M IPOs
fiercebiotech
Oct 10, 26
Parkinson’s-focused Aspen and bispecific biotech Bambusa plan IPOs
fiercebiotech
Oct 6, 26
CAR-T biotech Caribou makes ‘heartbreaking’ call to shrink headcount, halt pipeline
fiercebiotech
Oct 6, 26
BioSpace 40 Under 40 winners make their mark on biopharma
biospace
Sep 14, 26
Cellectis cans allogeneic CAR-Ts to hop aboard in vivo bandwagon
fiercebiotech
Sep 9, 26
CEO O’Day tells Fierce how Gilead’s cancer, inflammation expansion has reached ‘critical mass’
fiercebiotech
Sep 1, 26
ArsenalBio sheds most of staff in pivot to in vivo CAR-T
fiercebiotech
Jul 24, 26
Study of Yescarta patients reveals genetic red flags for CAR-T therapy side effects
fiercebiotech
May 29, 26
Allogene CEO to step down; Agios drug fails key test
biopharma dive